SCHEMBL4612265

SCHEMBL4612265

O=C1Nc2ccccc2C1CCCCN1CCN(c2cccc(Cl)c2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 15/20 1.00
DRD2 P14416 3/20 0.81
DRD1 P21728 2/20 0.81
HTR2A P28223 2/20 0.81
HTR2C P28335 2/20 0.81
ADRA1A P35348 2/20 0.81
HTR6 P50406 2/20 0.81
HTR1A P08908 1/20 0.80
DRD4 P21917 1/20 0.62
DRD3 P35462 1/20 0.62
KCNH2 Q12809 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4612036 0.91 HTR7 (0.83) HTR7DRD2DRD1HTR2AHTR2C
SCHEMBL4612207 0.89 HTR7 (1.00) HTR7DRD2DRD1HTR2AHTR2C
SCHEMBL4612142 0.89 HTR7 (1.00) HTR7DRD2DRD1HTR2AHTR2C
SCHEMBL4611819 0.89 HTR7 (0.80) HTR7DRD2DRD1HTR2AHTR2C
SCHEMBL4613692 0.89 HTR7 (0.80) HTR7DRD2DRD1HTR2AHTR2C
Hydrochloric Acid SCHEMBL4611865 0.88 HTR7 (0.98) HTR7DRD2DRD1HTR2AHTR2C
Hydrochloric Acid SCHEMBL4614240 0.87 HTR7 (0.77) HTR7DRD2DRD1HTR2AHTR2C
SCHEMBL1456522 0.87 HTR7 (1.00) HTR7DRD2DRD1HTR2AHTR2C
SCHEMBL4611572 0.84 HTR7 (0.72) HTR7DRD2DRD1HTR2AHTR2C
SCHEMBL27702281 0.84 HTR7 (0.74) HTR7DRD2DRD1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751106-B1 PIPERAZINE DERIVATIVES OF ALKYL OXINDOLES EGIS GYOGYSZERGYAR NYRT (HU) 2008-10-29 EP claimed
US-20070219209-A1 Piperazine Derivatives Of Alkyl Oxindoles GYÓGYSZERGYÁR RT. (HU) 2007-09-20 US claimed
EP-1751106-A1 PIPERAZINE DERIVATIVES OF ALKYL OXINDOLES EGIS Gyógyszergyár Nyrt (HU) 2007-02-14 EP claimed
WO-2005108363-A1 PIPERAZINE DERIVATIVES OF ALKYL OXINDOLES EGIS GYÓGYSZERGYÁR NYRT. (HU) 2005-11-17 WO claimed
EP-1751106-B1 PIPERAZINE DERIVATIVES OF ALKYL OXINDOLES EGIS GYOGYSZERGYAR NYRT (HU) 2008-10-29 EP disclosed
CN-101061094-A Piperazine derivatives for alkyloxindoles EGYT GYOGYSZERVEGYESZETI GYAR (HU) 2007-10-24 CN disclosed
US-20070219209-A1 Piperazine Derivatives Of Alkyl Oxindoles GYÓGYSZERGYÁR RT. (HU) 2007-09-20 US disclosed
EP-1751106-A1 PIPERAZINE DERIVATIVES OF ALKYL OXINDOLES EGIS Gyógyszergyár Nyrt (HU) 2007-02-14 EP disclosed
WO-2005108363-A1 PIPERAZINE DERIVATIVES OF ALKYL OXINDOLES EGIS GYÓGYSZERGYÁR NYRT. (HU) 2005-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219209-A1 Piperazine Derivatives Of Alkyl Oxindoles TPH2, TPH1, HTR2C HTR7 30/4885DRD2 25/4885DRD1 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.